A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS AND EFFICACY OF MAU868 FOR THE TREATMENT OF BK VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS

Registry ID

MAU868-201

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

VERA THERAPEUTICS, INC

Start date

2020-11-12

Last update

2020-03-26

Conditions

• BK VIREMIA

View on source registry